Clinical aspects and management of AIDS-related Kaposi's sarcoma

European Journal of Cancer

Volumn 37, Issue 10, 2001, Pages 1288-1295

  Sparano, J A ^a  

^a ALBERT EINSTEIN CANCER CENTER   (United States)

Author keywords

AIDS; AIDS malignancies; AIDS KS; Kaposi's sarcoma; Therapy for AIDS KS; Treatment of KS

Indexed keywords

ACICLOVIR; ALITRETINOIN; ALPHA INTERFERON; ANGIOGENESIS INHIBITOR; ANTHRACYCLINE DERIVATIVE; ANTIRETROVIRUS AGENT; BLEOMYCIN; CIDOFOVIR; CYTOKINE; CYTOTOXIC AGENT; DAUNORUBICIN; DOXORUBICIN; ETOPOSIDE; FOSCARNET; GANCICLOVIR; IM 862; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; NAVELBINE; PACLITAXEL; PEPTIDE; RETINOIC ACID; RETINOID; THALIDOMIDE; TRANSACTIVATOR PROTEIN; TUMOR NECROSIS FACTOR; VINBLASTINE; VINCRISTINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AIDS RELATED COMPLEX; CANCER COMBINATION CHEMOTHERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL FEATURE; CLINICAL TRIAL; CRYOTHERAPY; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOREGULATION; KAPOSI SARCOMA; LASER SURGERY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIDE EFFECT; TREATMENT OUTCOME; VIRUS INFECTION;

EID: 0034968659     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(01)00109-5     Document Type: Article

References (65)

1. Kaposi's sarcoma: Epidemiology, pathogenesis, histology, clinical spectrum, staging criteria and therapy
2. Medical management of AIDS patients: Kaposi's sarcoma
3. Kaposi's sarcoma of the oral cavity: A study of 134 patients with a review of the pathogenesis, epidemiology, clinical aspects, and treatment
4. Pulmonary Kaposi's sarcoma: Clinical findings and results of therapy
5. Tumor and infection localization in AIDS patients. Ga-67 and T1-201 findings
6. Clinical aspects of AIDS related Kaposi's sarcoma
7. Kaposi's sarcoma and the acquired immunodeficiency syndrome: A proposal for a uniform evaluation, response and staging criteria
8. AIDS related Kaposi's sarcoma: Prospective validation of the AIDS Clinical Trials Group staging classification
9. Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression: Implications for AIDS-Kaposi's sarcoma pathogenesis
10. Tat protein of HIV-1 stimulates growth of AIDS-Kaposi's sarcoma-derived cells
11. Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: Prospective cohort study
12. Highly active antiretroviral therapy in HIV realted Kaposi's sarcoma
13. Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV related Kaposi's sarcoma
14. Reduction of Kapsoi's sarcoma lesions following treatment of AIDS with ritonavir
15. Highly active anti-retroviral therapy prolongs time to treatment failure in Kaposi's sarcoma
16. Treatment of AIDS related cutaneous Kaposi's sarcoma with topical alitretinoin (9-cis-retinoic) gel
17. Radiotherapy in the management of epidemic Kaposi's sarcoma: A retrospective study of 643 cases
18. Radiation therapy for acquired immunodeficiency syndrome related KS
19. Palliative radiation therapy for AIDS associated Kaposi's sarcoma by using a single fraction of 800 cGy
20. Intralesional vinblastine for cutaneous Kaposi's sarcoma associated with acquired immunodeficiency syndrome
21. Intralesional chemotherapy for Kaposi's sarcoma
22. Cryotherapy for cutaneous Kaposi's sarcoma associated with AIDS: A phase II trial
23. Cryosurgery in dermatology
24. Argon laser photocoagulation therapy of Kaposi's sarcoma: A clinical and histological evaluation
25. Pulsed-dye laser therapy for cutaneous Kaposi's sarcoma associated with acquired immunodeficiency syndrome
26. Vinblastine therapy for Kaposi's sarcoma in acquired immunodeficiency syndrome
27. Treatment of Kaposi's sarcoma and thrombocytopenia with vincristine in patients with the acquired immunodeficiency syndrome
28. Evidence of activity of vinorelbine (VNR) in patients with previously treated epidemic Kaposi's sarcoma (KS)
29. Treatment of Kaposi's sarcoma in acquiured immunodeficiency syndrome with an alternating vincristine-vinblastine regimen
30. Treatment of acquired immunodeficiency syndrome related Kaposi's sarcoma with bleomycin as a single agent
31. Continuous infusion bleomycin in AIDS-related Kaposi's sarcoma
32. Weekly doxorubicin in the treatment of patients with AIDS-related Kaposi's sarcoma
33. Weekly oral etoposide in patients with Kaposi's sarcoma associated with human immunodeficiency virus infection: A phase I multicenter trial of the AIDS Clinical Trials Group
34. Systemic treatment of AIDS-related Kaposi's sarcoma. Results of a randomized trial
35. Management of AIDS associated Kaposi's sarcoma: A multidisciplinary perspective
36. Treatment of advanced Kaposi's sarcoma using a combination of bleomycin and vincristine
37. Potentiation of cytotoxicity of Kaposi's sarcoma related to immunodefieicny syndrome (AIDS) by liposome encapsulated doxorubicin
38. Pharmacokinetics, tumor localization, and safety of pegylated-liposomal doxorubicin in patients with AIDS-related Kaposi's sarcoma
39. Selective tumour localization and improved therapeutic index of anthracyclines in long circulating liposomes
40. A phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin (DaunoXome) in the treatment of advanced AIDS-related Kaposi's sarcoma
41. Randomized phase III trial of liposomal daunorubicin (DaunoXome) versus doxorubicin, bleomycin, vincristine (ABV) in AIDS-related Kaposi's sarcoma
42. Pegylated liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: Results of a randomized phase III clinical trial
43. Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma
44. Efficacy of pegylated-liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma after failure of standard chemotherapy
45. Phase II trial of liposomal daunorubicin in the treatment of AIDS-related pulmonary Kaposi's sarcoma
46. Treatment of HIV-associated Kaposi's sarcoma with paclitaxel
47. Phase II trial with dose titration of paclitaxel for the therapy of Human Immunoficiency Virus-associated Kaposi's sarcoma
48. Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma
49. Preliminary results of a phase II study of oral thalidomide in patients with AIDS-related Kaposi's sarcoma
50. Results of a randomized study of IM862 nasal solution in the treatment of AIDS-related Kaposi's sarcoma
51. Retinoid antagonism of NF-IL-6: Insight into the mechanism of anti-proliferative effects of retinoids in Kaposi's sarcoma
52. Topical treatment of epidemic Kaposi's sarcoma with all trans retinoic acid
53. All-trans retinoic acid for the treatment of AIDS-related Kaposi's sarcoma. Results of a pilot phase II study
54. A multicenter phase II/III study of ATRAGEN (Tretinoin liposomal) in patients with AIDS-associated Kaposi's sarcoma
55. Oral 9-cis-retinoic acid in AIDS-related-Kaposi's sarcoma. AIDS malignancy consortium study 002
56. Interim analysis of phase II study (Protocol L1057-280 of panretin capsules for AIDS related Kaposis' sarcoma
57. Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs
58. In vitro antiviral drug sensitivity of the Kaposi's sarcoma-associated herpesvirus
59. Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant
60. Inhibition of HHV-8 infection by α-interferon
61. Recombinant alpha-2 interferon for Kaposi's sarcoma associated with the acquired immunodeficiency syndrome
62. Kaposi's sarcoma and the acquired immunodeficiency syndrome: Treatment with high and low doses of recombinant leukocyte A interferon
63. The role of interferon in the therapy of epidemic Kaposi's sarcoma
64. Prospective, randomized trial of two dose levels of interferon alfa with zidovudine for the treatment of Kaposi's sarcoma associated with human immunodeficiencyh virus infection: A Canadian HIV Clinical Trials Network Study
65. Interferon and zidovudine: Safety, tolerance, and clinical and virological effects in patients with Kaposi's sarcoma associated with the acquired immunodeficiency syndrome (AIDS)